Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc (NY: AZN )

54.17 USD UNCHANGED
Last Price Updated: 7:43 PM EDT, Sep 24, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Astrazeneca Plc

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma
AVEO Oncology (Nasdaq: AVEO) today announced the presentation of results from the Phase 1b portion of the Phase 1b/2 DEDUCTIVE clinical trial of tivozanib (FOTIVDA®), AVEO’s vascular endothelial growth... 
From Business Wire News Releases
Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC
From GlobeNewswire News Releases
AstraZeneca to Showcase Transformative Data Across Diverse Pipeline at World Conference on Lung Cancer
AstraZeneca will present new data from across the innovative lung cancer portfolio at the IASLC 2020 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of... 
From Business Wire News Releases
Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca
Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a research collaboration with AstraZeneca(LSE/STO/Nasdaq: AZN)... 
From PR Newswire
Researchers Seek to Better Understand Psychedelics' Role in New Therapies
FinancialBuzz.com News Commentary 
From PR Newswire
Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics
From GlobeNewswire News Releases
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced collaborations with global biopharmaceutical companies Amgen (NASDAQ:AMGN), AstraZeneca (LSE/STO/Nasdaq: AZN),... 
From Business Wire News Releases
Thinking about trading options or stock in Moderna, Plug Power, Aurora Cannabis, AstraZeneca, or Bank of America?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, PLUG, ACB, AZN, and BAC. 
From PR Newswire
FARXIGA Granted Priority Review in the US for the Treatment of Patients With Chronic Kidney Disease
AstraZeneca’s FARXIGA (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type 2 diabetes (T2D). 
From Business Wire News Releases
Thinking about buying stock in AzurRx BioPharma, AstraZeneca, Marathon Patent Group, Mogo Inc, or Phunware?
InvestorsObserver issues critical PriceWatch Alerts for AZRX, AZN, MARA, MOGO, and PHUN. 
From PR Newswire
Thinking about buying stock in AstraZeneca, Pfizer, JD.Com, General Electric, or Boeing?
InvestorsObserver issues critical PriceWatch Alerts for AZN, PFE, JD, GE, and BA. 
From PR Newswire
Thinking about trading options or stock in General Electric, Tesla, Flux Power, AstraZeneca, or Electrameccanica Vehicles?
InvestorsObserver issues critical PriceWatch Alerts for GE, TSLA, FLUX, AZN, and SOLO. 
From PR Newswire
Thinking about trading options or stock in Pfizer, General Electric, Apple, Blink Charging, or AstraZeneca?
InvestorsObserver issues critical PriceWatch Alerts for PFE, GE, AAPL, BLNK, and AZN. 
From PR Newswire
Compugen Announces First Development Milestone in License Agreement with AstraZeneca for the Development of Bispecific and Multi-specific Antibody Products
Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today progress from its ongoing license agreement with AstraZeneca... 
From PR Newswire
ADDING MULTIMEDIA TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer
AstraZeneca’s TAGRISSO® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung... 
From Business Wire News Releases
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
Financialnewsmedia.com News Commentary 
From PR Newswire
ALEXION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alexion Pharmaceuticals, Inc. - ALXN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Alexion Pharmaceuticals, Inc. (NasdaqGS: ALXN)... 
From PR Newswire
Thinking about trading options or stock in General Electric, AstraZeneca, Draftkings, BioNTech, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for GE, AZN, DKNG, BNTX, and CCL. 
From PR Newswire
ALEXION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ALXN and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout
From GlobeNewswire News Releases
Should you invest in Nio, AstraZeneca, Pluralsight, Walt Disney, or Dropbox?
InvestorsObserver issues critical PriceWatch Alerts for NIO, AZN, PS, DIS, and DBX. 
From PR Newswire
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development 
From Business Wire News Releases
Thinking about trading options or stock in Rocket Pharmaceuticals, AstraZeneca, Virgin Galactic, General Motors, or Coca-Cola?
InvestorsObserver issues critical PriceWatch Alerts for RCKT, AZN, SPCE, GM, and KO. 
From PR Newswire
ENHERTU (fam-trastuzumab deruxtecan-nxki) Continues to Demonstrate Durable Responses with New Data From DESTINY-Breast01 in HER2-positive Metastatic Breast Cancer
Updated results from the positive DESTINY-Breast01 Phase II trial showed AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) continued to... 
From Business Wire News Releases
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Apple, Alibaba, AstraZeneca, Tesla, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, BABA, AZN, TSLA, and CCL. 
From PR Newswire
Health Crisis-Induced Post-Traumatic Stress Disorder Creates Growing Need for Treatment Options
- FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Health Crisis-Induced Post-Traumatic Stress Disorder Creates Growing Need for Treatment Options
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.